IDH1 and acute myeloid leukemia: The somatic mutations of IDH1 play a pivotal role in the initiation and maintenance of various types of cancers [1,2], such as AML [3,4,5], intrahepatic cholangiocarcinoma [6], grade II–III gliomas [7], and secondary glioblastomas [8].